Literature DB >> 23829616

Of chimeric antigen receptors and antibodies: OX40 and 41BB costimulation sharpen up T cell-based immunotherapy of cancer.

Andreas A Hombach1, Hinrich Abken.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23829616     DOI： 10.2217/imt.13.54

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  8 in total

Review 1.  The basics of CAR T design and challenges in immunotherapy of solid tumors - Ovarian cancer as a model.

Authors:  Xuequn Xu; Jin Qiu; Yi Sun
Journal:  Hum Vaccin Immunother       Date:  2017-03-08       Impact factor: 3.452

2.  Impact of a New Fusion Receptor on PD-1-Mediated Immunosuppression in Adoptive T Cell Therapy.

Authors:  Sebastian Kobold; Simon Grassmann; Michael Chaloupka; Christopher Lampert; Susanne Wenk; Fabian Kraus; Moritz Rapp; Peter Düwell; Yi Zeng; Jan C Schmollinger; Max Schnurr; Stefan Endres; Simon Rothenfußer
Journal:  J Natl Cancer Inst       Date:  2015-06-23       Impact factor: 13.506

3.  Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.

Authors:  Adam Lynch; William Hawk; Emily Nylen; Sean Ober; Pierre Autin; Amorette Barber
Journal:  Immunology       Date:  2017-07-27       Impact factor: 7.397

4.  Blinatumomab-induced T cell activation at single cell transcriptome resolution.

Authors:  Yi Huo; Zhen Sheng; Daniel R Lu; Daniel C Ellwanger; Chi-Ming Li; Oliver Homann; Songli Wang; Hong Yin; Ruibao Ren
Journal:  BMC Genomics       Date:  2021-03-01       Impact factor: 3.969

Review 5.  CAR models: next-generation CAR modifications for enhanced T-cell function.

Authors:  Daniel Abate-Daga; Marco L Davila
Journal:  Mol Ther Oncolytics       Date:  2016-05-18       Impact factor: 7.200

Review 6.  B-cell maturation antigen targeting strategies in multiple myeloma treatment, advantages and disadvantages.

Authors:  Shirin Teymouri Nobari; Jafar Nouri Nojadeh; Mehdi Talebi
Journal:  J Transl Med       Date:  2022-02-10       Impact factor: 5.531

Review 7.  Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers.

Authors:  Aaron J Harrison; Xin Du; Bianca von Scheidt; Michael H Kershaw; Clare Y Slaney
Journal:  Immunother Adv       Date:  2021-07-31

Review 8.  Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T Cells.

Authors:  Markus Chmielewski; Andreas A Hombach; Hinrich Abken
Journal:  Front Immunol       Date:  2013-11-11       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.